Pharmacokinetics of flumazenil in fulminant hepatic failure
โ Scribed by C. C. D. Rijt; R. H. Drost; S. W. Schalm; M. Schramel
- Publisher
- Springer
- Year
- 1991
- Tongue
- English
- Weight
- 103 KB
- Volume
- 41
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The clinicopathological features of 38 patients admitted consecutively for fulminant hepatic failure were studied. Histopathological material was reviewed in all patients. Both percutaneous and whole livers (either explanted or autopsy specimens) were available in 16 patients: whole livers only in 1
The incidence of chronic hepatitis in the overall liver trans-Specimens were processed routinely into paraffin blocks and stained with the following: hematoxylin and eosin, hematoxylin van Gieson, reticulin, orcein, Perl's reaction, and periodic acid Schiff with and without diastase pretreatment. Sp
After reading the article by Taura et al. with great interest, we really appreciate the ingenious work they have done. 1 In this study, they found type I collagen-producing cells do not originate from hepatocytes in a triple transgenic mouse model. Hepatocytes in vivo neither express mesenchymal mar
We read with great interest the paper by Tsubouchi et al. (1) on the hepatocyte growth factor (hHGF) in the blood of patients with fulminant hepatic failure (FHF). These authors have already elegantly reported the purification and partial characterization of hHGF from the plasma of a patient with FH